Regulating Stem Cell Products

The US Food and Drug Administration's (FDA) Biological Response Modifiers Advisory Committee convened in July to begin the process of formalizing regulations for the development of stem cell products. Dr. Jay Siegel, director of the FDA's Office of Therapeutic Research and Review, said that they are trying to get information on what would constitute appropriate controls and testing to set the grounds for human research.